Famciclovirum [Inn-Latin] en es it fr

Famciclovirum [Inn-Latin] Brand names, Famciclovirum [Inn-Latin] Analogs

Famciclovirum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Famciclovirum [Inn-Latin] Chemical_Formula


Famciclovirum [Inn-Latin] RX_link


Famciclovirum [Inn-Latin] fda sheet

Famciclovirum_[Inn-Latin] FDA

Famciclovirum [Inn-Latin] msds (material safety sheet)

Famciclovirum [Inn-Latin] Synthesis Reference

Geen, et al.; Tetrahedron Lett.; 33; 32;4609-4612(1992).

Famciclovirum [Inn-Latin] Molecular Weight

321.332 g/mol

Famciclovirum [Inn-Latin] Melting Point

102-104 oC

Famciclovirum [Inn-Latin] H2O Solubility

No information avaliable

Famciclovirum [Inn-Latin] State


Famciclovirum [Inn-Latin] LogP


Famciclovirum [Inn-Latin] Dosage Forms


Famciclovirum [Inn-Latin] Indication

For the treatment of acute herpes zoster (shingles). Also for the treatment or suppression of recurrent genital herpes in immunocompetent patients and treatment of recurrent mucocutaneous herpes simplex infections in HIV infected patients.

Famciclovirum [Inn-Latin] Pharmacology

Famciclovir is a prodrug that undergoes rapid biotransformation to the active antiviral compound penciclovir. Penciclovir is an anti-viral drug which has inhibitory activity against herpes simplex virus types 1 (HSV-1) and 2 (HSV-2) and varicella zoster virus (VZV). Therefore, herpes viral DNA synthesis and replication are selectively inhibited.

Famciclovirum [Inn-Latin] Absorption

77 %

Famciclovirum [Inn-Latin] side effects and Toxicity

Symptoms of overdose include constipation, diarrhea, dizziness, fatigue, fever, headache, nausea, and vomiting.

Famciclovirum [Inn-Latin] Patient Information

Famciclovirum [Inn-Latin] Organisms Affected

Human Herpes Virus